Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 18;12(1):885.
doi: 10.1038/s41598-022-04904-w.

Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency

Affiliations

Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency

Valentina Guarnotta et al. Sci Rep. .

Abstract

To assess the differences between patients with normal glucose tolerance (NGT) and prediabetes/diabetes mellitus (DM) in secondary adrenal insufficiency (SAI). We cross-sectionally evaluated 102, out of a total of 140, patients with SAI, who were on hydrocortisone (HC) (n = 50) and cortisone acetate (n = 52) replacement therapy. Clinical, anthropometric, and metabolic parameters were compared in patients with NGT (n = 60) and DM (n = 42). Patients with prediabetes/DM have a more marked family history of DM (p = 0.002), BMI (p < 0.001), higher waist circumference (p < 0.001), total cholesterol (p = 0.012), LDL-cholesterol (p = 0.004), triglycerides (p = 0.031), fasting glucose (p = 0.002), fasting insulin (p = 0.035), glutamate pyruvate transaminase (p = 0.018), HOMA-IR (p = 0.039), area under curves of glucose (p = 0.001) and insulin (p = 0.002), HbA1c (p < 0.001), Visceral adiposity index (VAI) (p = 0.038) and lower ISI-Matsuda (p = 0.008) and oral disposition index (p < 0.001) than patients with NGT. Multivariate analysis showed that family history of DM and VAI are independent predictive factors for DM in patients with SAI. Family history of DM and VAI can be predictors of the development of DM in patients with SAI and need to be investigated during steroid replacement therapy. Interestingly, the type and the dose of replacement steroid do not impact on diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
A Forest Plot showing odds ratio values and 95% confidence intervals for: DM and SAI, adjusted by BMI and dose of cortisone acetate. The x-axis represents the odds ratio (circles) and 95% confidence intervals (whiskers). The dashed vertical line indicates an OR value of 1.

References

    1. Ngaosuwan K, Johnston DG, Godsland IF, Cox J, Majeed A, Quint JK, et al. Increased mortality risk in patients with primary and secondary adrenal insufficiency. J. Clin. Endocrinol. Metab. 2021;106:e2759–e2768. doi: 10.1210/clinem/dgab096. - DOI - PubMed
    1. Stewart PM, Biller BM, Marelli C, Gunnarsson C, Ryan MP, Johannsson G. Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency. J. Clin. Endocrinol. Metab. 2016;101:4843–4850. doi: 10.1210/jc.2016-2221. - DOI - PubMed
    1. Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, et al. Management of endocrine disease: Risk of overtreatment in patients withadrenal insufficiency: Current and emerging aspects. Eur. J. Endocrinol. 2017;177:R231–R248. doi: 10.1530/EJE-17-0154. - DOI - PubMed
    1. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2016;101:364–389. doi: 10.1210/jc.2015-1710. - DOI - PMC - PubMed
    1. Graziadio C, Hasenmajer V, Venneri MA, Gianfrilli D, Isidori AM, Sbardella E. Glycometabolic alterations in secondary adrenal insufficiency: Does replacement therapy play a role? Front. Endocrinol. (Lausanne) 2018;9:434. doi: 10.3389/fendo.2018.00434. - DOI - PMC - PubMed